MLEC Company Profile and Key Details

Moolec Science S.A. (NASDAQ:MLEC) closed at $8.09 USD, gaining $0.82 (11.28%) from the previous close of $7.27. The stock is currently mid-range between its 52-week high and low $3.08 and $157.05. With a market capitalization of about $5.87 million, Moolec Science S.A. is classified as a micro-cap and shows lower-than-market volatility (beta ~-0.37). Key stats such as the average daily volume over the past year has been around 1.26 million shares, volume is running light vs its 52-week average. Headquartered in Luxembourg, , Moolec Science S.A. operates in the Healthcare sector and the Biotechnology industry. Led by CEO Alejandro Antalich, the company employs approximately 52 people and listed since March 02, 2021. Moolec Science SA, a science-based ingredient company, focuses on producing animal proteins in plants through Molecular Farming, a disruptive technology in the alternative protein landscape.

MLEC has shown mixed momentum, gaining 6.81% over the past week and -54.97% over the past quarter, though year-to-date performance is up 14.95%. Short-term trend indicators are mixed aligned (SMA20 61.76%, SMA50 127.07%, SMA200 -58.79%). The stock’s 14-day RSI is 71.72 (overbought), while the ATR of 2.89 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -90.25% below its high and over 397.97% above its low. Average 10-day trading volume of 16.00 thousand shares is below the 3-month average of 1.32 million, indicating normal recent market interest.

Moolec Science S.A. trades at a P/E ratio of -0.03, slightly below the S&P 500 average, with a price-to-sales ratio of 0.02 and a price-to-book ratio of -0.05 indicating negative book value, which may reflect financial stress. The P/FCF stands at -0.17, also below market averages.

Moolec Science S.A. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around -$0.77. This means the shares are trading below this model’s fair value.

Moolec Science S.A. generated EPS of -$32.24 over the past year. Five-year average earnings growth is -583.54%. The latest quarter delivered EPS of -$0.70. The next quarter is forecast at $nan. Next year's EPS is expected at $10.53. Moolec Science S.A. earnings surprise history is a mixed track record. The quarter that ended October 01, 2025, missed forecasts by 0.0%. The prior quarter beat by 900.0%. Over the last six quarters, Apple has recorded several small beats. These include -42.86% in May 30, 2024.

Moolec Science S.A. has 4.00 million shares outstanding. The public float is 897.82 thousand shares, elevated short interest at 1.43% of float. This equals 12.39 thousand shares. The short ratio is 3.16 days. Institutional investors hold 0.32% of the float. Insiders own 21.06%.